Demonstrated in a variety of malignancies with chronic myelogenous leukemia the most sensitive disease to date.
Reported to occur in CML, AML, non-Hodgkin’s lymphoma, Hodgkin’s disease, multiple myeloma renal cell cancer and breast cancer.
Demonstrated in a variety of malignancies with chronic myelogenous leukemia the most sensitive disease to date.
Reported to occur in CML, AML, non-Hodgkin’s lymphoma, Hodgkin’s disease, multiple myeloma renal cell cancer and breast cancer.